InstituteOfSurgicalPathologyFreiburg

Oliver Schilling
oliver.schilling@mol-med.uni-freiburg.de

Request Access

Dataset ID	Description	Technology	Samples
EGAD00010002330	We performed a proteomic serum profiling of patients with non-metastasized breast cancer (BC) who received neoadjuvant chemotherapy (NACT). Samples were collected at three timepoints during NACT. Furthermore, we compared serum samples of BC patients pre-NACT to a control group of healthy volunteers.	Qexactive Plus	84